Saturday 17 October 2026
Export IONM’s income statement to Excel — free account
Assure Holdings Corp.
IONM Healthcare Medical Care Facilities
Operating cash flow growth for three consecutive years.
0.00
0.00
NaN
Follow IONM
| Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 2 | 4 | 3 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(24.39) | (4.52) | 2.84 | 0.20 | 2.04 | 39.46 | — | — |
P/S ratio |
4.64 | 8.95 | 2.17 | 10.57 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(62.84) | (6.85) | 4.94 | 0.42 | 4.18 | 7.70 | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | 2.50 | — | (0.90) | — | — | — |
P/Operating CF |
(5.33) | (1.96) | (15.76) | (54.40) | 0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
0.00 | 0.77 | 2.19 | 1.94 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 1.04 | 3.04 | 3.05 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
60.08 | 35.31 | 2.53 | 11.13 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(3.04) | (2.24) | (5.52) | (15.49) | 0.00 | 0.00 | 0.00 | 0.00 |
EV/FCF |
(2.99) | (2.22) | (5.39) | (13.76) | 0.00 | 0.00 | 0.00 | 0.00 |
Quick Ratio |
0.17 | 3.23 | 8.60 | 2.57 | 2.68 | 6.90 | 7.05 | 3.63 |
Current Ratio |
0.30 | 4.68 | 10.22 | 3.29 | 2.91 | 6.93 | 7.10 | 3.63 |
Net Debt/EBITDA |
(0.71) | (0.84) | (11.34) | (0.13) | 3.52 | 0.01 | (0.04) | 0.07 |
Debt/Assets |
189.77% | 54.95% | 29.85% | 18.88% | 23.17% | 2.97% | 0.00% | 5.32% |
Debt/Equity |
(0.93) | 2.44 | 0.50 | 0.33 | 1.02 | 0.11 | 0.19 | 0.11 |
Asset Turnover |
0.02 | 0.01 | 0.71 | 0.09 | 0.54 | 0.83 | 5.03 | 0.42 |
Operating CF/Net income |
0.19 | 0.25 | 4.85 | 0.21 | (1.56) | 0.19 | 0.28 | 0.24 |
Capex/Depreciation |
0.00 | (0.01) | 0.00 | (0.31) | (0.09) | 0.00 | 0.00 | 0.00 |
Interest Coverage |
(9.89) | (13.45) | (1.97) | (30.57) | 9.41 | 1,315.22 | 0.00 | 0.00 |
| 528.43% | (174.96%) | (11.44%) | (102.73%) | 34.27% | 82.20% | (196.42%) | 118.69% | |
| (164.20%) | (82.89%) | (6.72%) | (38.54%) | 8.27% | 24.12% | (175.29%) | 23.52% | |
ROIC |
0.00% | (77.04%) | (3.38%) | (47.83%) | 7.30% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
168.30% | (164.58%) | (8.02%) | (84.74%) | 12.17% | 18.80% | (32.33%) | 88.06% |
Average Days of Receivables |
5,154.37 | 11,735.02 | 349.42 | 1,565.54 | 638.18 | 619.52 | 436.27 | 297.32 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
5,303.53% | 3,198.51% | 54.42% | 306.50% | 55.64% | 41.31% | 28.69% | 24.56% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.17 | 0.21 | 0.17 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
(117.65%) | 218.47% | 6.55% | 15.55% | 7.10% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(13.62) | 1.06 | 0.29 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
426.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(2,514.50%) | (714.38%) | (4.11%) | (41.30%) | (41.30%) | (41.30%) | (41.30%) | (41.30%) |
Free Cash Flow Yield |
(432.68%) | (177.86%) | (21.60%) | (7.65%) | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
1.07 | 11.27 | 895.46 | 175.32 | 928.01 | 30.64 | 1.90 | 3.05 |
Operating CF per Share |
(21.21) | (177.37) | (410.21) | (158.41) | (221.36) | 1.68 | (0.19) | 0.42 |
Capex per Share |
0.00 | (1.91) | 0.00 | (15.87) | (2.51) | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(21.21) | (179.28) | (410.21) | (174.28) | (223.87) | 1.68 | (0.19) | 0.42 |
Cash per Share |
0.52 | 21.65 | 123.31 | 218.21 | 3.09 | 1.72 | 0.03 | 0.04 |
Shareholders Equity per Share |
(64.49) | 130.74 | 888.22 | 955.67 | 526.96 | 16.28 | 0.29 | 1.65 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(64.49) | 130.74 | 888.22 | 955.67 | 526.96 | 16.28 | 0.29 | 1.65 |
Free Cash Flow |
(5.04) | (7.49) | (13.37) | (3.50) | (4.28) | 0.60 | (1.23) | 0.64 |
Working Capital |
(15.49) | 18.29 | 34.29 | 17.39 | 22.11 | 16.39 | 13.21 | 2.82 |
Capital Expenditures |
— | (0.08) | — | (0.32) | (0.05) | (0.22) | (0.03) | (0.08) |
Net Current Asset Value |
(16.13) | 4.48 | 18.55 | 10.54 | (0.61) | 3.63 | (0.27) | 1.42 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.17 | 0.00 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.00 | 1,219.33 | 14.20 | 2.85 | 2.57 | 0.60 | 0.41 | 0.25 |
Cash ROIC |
529.28% | (38.05%) | (28.20%) | (11.70%) | (20.95%) | 8.47% | (49.49%) | 22.39% |
Accounts Receivable Turnover |
0.03 | 0.02 | 1.36 | 0.15 | 0.72 | 0.65 | 1.33 | 0.50 |
Accounts Payable Turnover |
0.47 | 0.99 | 5.65 | 2.19 | 1.51 | 1.38 | 2.02 | 0.73 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
1,104.54 | 420.79 | 55.93 | 132.45 | 321.54 | 278.10 | 323.64 | 103.99 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
9.37 | 21.54 | 21.53 | 23.05 | 24.74 | 16.80 | 9.47 | 9.47 |
Average Payables |
5.17 | 2.56 | 2.53 | 3.62 | 3.29 | 2.11 | 1.12 | 1.12 |
Average Assets |
15.88 | 36.33 | 41.03 | 39.01 | 32.85 | 13.17 | 2.51 | 11.30 |
Average Common Equity |
(4.93) | 17.21 | 24.08 | 14.64 | 7.93 | 3.86 | 2.24 | 2.24 |
Columns are period end dates